192 related articles for article (PubMed ID: 34822608)
1. The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody.
Luz D; Gómez FD; Ferreira RL; Melo BS; Guth BEC; Quintilio W; Moro AM; Presta A; Sacerdoti F; Ibarra C; Chen G; Sidhu SS; Amaral MM; Piazza RMF
Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822608
[TBL] [Abstract][Full Text] [Related]
2. Human Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects
Luz D; Amaral MM; Sacerdoti F; Bernal AM; Quintilio W; Moro AM; Palermo MS; Ibarra C; Piazza RMF
Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30513821
[TBL] [Abstract][Full Text] [Related]
3. Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.
Melli LJ; Zylberman V; Hiriart Y; Lauche CE; Baschkier A; Pardo R; Miliwebsky E; Chinen I; Rivas M; Goldbaum FA; Ugalde JE; Comerci DJ; Ciocchini AE
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31826960
[TBL] [Abstract][Full Text] [Related]
4. A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.
Tremblay JM; Mukherjee J; Leysath CE; Debatis M; Ofori K; Baldwin K; Boucher C; Peters R; Beamer G; Sheoran A; Bedenice D; Tzipori S; Shoemaker CB
Infect Immun; 2013 Dec; 81(12):4592-603. PubMed ID: 24082082
[TBL] [Abstract][Full Text] [Related]
5. Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2.
Jeong KI; Tzipori S; Sheoran AS
J Infect Dis; 2010 Apr; 201(7):1081-3. PubMed ID: 20196656
[TBL] [Abstract][Full Text] [Related]
6. Comparative Characterization of Shiga Toxin Type 2 and Subtilase Cytotoxin Effects on Human Renal Epithelial and Endothelial Cells Grown in Monolayer and Bilayer Conditions.
Álvarez RS; Sacerdoti F; Jancic C; Paton AW; Paton JC; Ibarra C; Amaral MM
PLoS One; 2016; 11(6):e0158180. PubMed ID: 27336788
[TBL] [Abstract][Full Text] [Related]
7. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G
Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345
[TBL] [Abstract][Full Text] [Related]
8. Interaction between Shiga toxin and monoclonal antibodies: binding characteristics and in vitro neutralizing abilities.
Rocha LB; Luz DE; Moraes CT; Caravelli A; Fernandes I; Guth BE; Horton DS; Piazza RM
Toxins (Basel); 2012 Sep; 4(9):729-47. PubMed ID: 23105978
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli.
Luz D; Chen G; Maranhão AQ; Rocha LB; Sidhu S; Piazza RM
PLoS One; 2015; 10(3):e0120481. PubMed ID: 25790467
[TBL] [Abstract][Full Text] [Related]
10. Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cells.
Amaral MM; Sacerdoti F; Jancic C; Repetto HA; Paton AW; Paton JC; Ibarra C
PLoS One; 2013; 8(7):e70431. PubMed ID: 23936204
[TBL] [Abstract][Full Text] [Related]
11. Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.
Ludwig K; Sarkim V; Bitzan M; Karmali MA; Bobrowski C; Ruder H; Laufs R; Sobottka I; Petric M; Karch H; Müller-Wiefel DE
J Clin Microbiol; 2002 May; 40(5):1773-82. PubMed ID: 11980959
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of monoclonal antibodies against Shiga toxin 2 and their application for toxin detection in milk.
He X; McMahon S; Skinner C; Merrill P; Scotcher MC; Stanker LH
J Immunol Methods; 2013 Mar; 389(1-2):18-28. PubMed ID: 23279946
[TBL] [Abstract][Full Text] [Related]
13. Ouabain Protects Human Renal Cells against the Cytotoxic Effects of Shiga Toxin Type 2 and Subtilase Cytotoxin.
Amaral MM; Girard MC; Álvarez RS; Paton AW; Paton JC; Repetto HA; Sacerdoti F; Ibarra CA
Toxins (Basel); 2017 Jul; 9(7):. PubMed ID: 28718802
[TBL] [Abstract][Full Text] [Related]
14. New high-affinity monoclonal antibodies against Shiga toxin 1 facilitate the detection of hybrid Stx1/Stx2 in vivo.
Skinner C; Patfield S; Stanker LH; Fratamico P; He X
PLoS One; 2014; 9(6):e99854. PubMed ID: 24914553
[TBL] [Abstract][Full Text] [Related]
15. Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls.
Guirro M; Piazza RM; de Souza RL; Guth BE
BMC Infect Dis; 2014 Jun; 14():320. PubMed ID: 24919599
[TBL] [Abstract][Full Text] [Related]
16. Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a
Petro CD; Trojnar E; Sinclair J; Liu ZM; Smith M; O'Brien AD; Melton-Celsa A
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670557
[TBL] [Abstract][Full Text] [Related]
17. Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome.
Ludwig K; Karmali MA; Sarkim V; Bobrowski C; Petric M; Karch H; Müller-Wiefel DE;
J Clin Microbiol; 2001 Jun; 39(6):2272-9. PubMed ID: 11376069
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy and pharmacokinetics of human/mouse chimeric anti-Stx1 and anti-Stx2 antibodies in mice.
Melton-Celsa AR; Carvalho HM; Thuning-Roberson C; O'Brien AD
Clin Vaccine Immunol; 2015 Apr; 22(4):448-55. PubMed ID: 25716230
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Shiga Toxin 1, 2 and Their Subunits on Cytokine and Chemokine Expression by Human Macrophage-Like THP-1 Cells.
Brandelli JR; Griener TP; Laing A; Mulvey G; Armstrong GD
Toxins (Basel); 2015 Oct; 7(10):4054-66. PubMed ID: 26473922
[TBL] [Abstract][Full Text] [Related]
20. [Development of a product anti-Shiga toxin for prevention of the hemolytic uremic syndrome].
Hiriart Y; Pardo R; Bukata L; Lauché C; Muñoz L; Colonna M; Goldbaum F; Sanguineti S; Zylberman V
Medicina (B Aires); 2018; 78(2):107-112. PubMed ID: 29659360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
